ESR1 and breast cancer: The most prescribed SERM, Tamoxifen, is recommended by the ASCO (American Society of Clinical Oncology) guidelines for postmenopausal ER positive BC and for premenopausal BC patients for up to 10 years; it has been the most used treatment option in the past three decades [48].